Invesco’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-65,578
| Closed | -$1.03M | – | 4012 |
|
|
2024
Q1 | $1.03M | Buy |
65,578
+44,254
| +208% | +$681K | ﹤0.01% | 2973 |
|
|
2023
Q4 | $344K | Buy |
21,324
+4,456
| +26% | +$56.8K | ﹤0.01% | 3391 |
|
|
2023
Q3 | $215K | Sell |
16,868
-77,554
| -82% | -$1.07M | ﹤0.01% | 3569 |
|
|
2023
Q2 | $1.33M | Buy |
94,422
+318
| +0.3% | +$4.55K | ﹤0.01% | 2777 |
|
|
2023
Q1 | $1.45M | Buy |
94,104
+26,229
| +39% | +$438K | ﹤0.01% | 2761 |
|
|
2022
Q4 | $1.11M | Sell |
67,875
-277,374
| -80% | -$4.51M | ﹤0.01% | 2882 |
|
|
2022
Q3 | $6.39M | Sell |
345,249
-312,409
| -48% | -$4.9M | ﹤0.01% | 2070 |
|
|
2022
Q2 | $8.65M | Buy |
657,658
+596,374
| +973% | +$6.58M | ﹤0.01% | 1948 |
|
|
2022
Q1 | $569K | Buy |
61,284
+35,157
| +135% | +$299K | ﹤0.01% | 3322 |
|
|
2021
Q4 | $255K | Sell |
26,127
-444,640
| -94% | -$8.36M | ﹤0.01% | 3687 |
|
|
2021
Q3 | $16M | Buy |
470,767
+56,452
| +14% | +$1.8M | ﹤0.01% | 1710 |
|
|
2021
Q2 | $15.2M | Buy |
414,315
+7,112
| +2% | +$275K | ﹤0.01% | 1794 |
|
|
2021
Q1 | $18.3M | Buy |
407,203
+9,484
| +2% | +$442K | ﹤0.01% | 1607 |
|
|
2020
Q4 | $22.7M | Buy |
397,719
+100,888
| +34% | +$5.98M | 0.01% | 1371 |
|
|
2020
Q3 | $15.2M | Sell |
296,831
-58,226
| -16% | -$2.85M | 0.01% | 1448 |
|
|
2020
Q2 | $21.2M | Buy |
+355,057
| New | +$19M | 0.01% | 1249 |
|
|
2020
Q1 | – | Sell |
-51,810
| Closed | -$3.23M | – | 3747 |
|
|
2019
Q4 | $3.23M | Buy |
51,810
+28,139
| +119% | +$1.34M | ﹤0.01% | 2418 |
|
|
2019
Q3 | $803K | Buy |
+23,671
| New | +$701K | ﹤0.01% | 3091 |
|
|
2018
Q4 | – | Sell |
-45,174
| Closed | -$1.75M | – | 3889 |
|
|
2018
Q3 | $1.75M | Buy |
+45,174
| New | +$1.67M | ﹤0.01% | 2848 |
|
Other funds holding DCPH
Invesco's DCPH Position: Q2 2024 in Review
Invesco sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 65,578 shares — an estimated $1.03M sold.
Invesco first reported a position in DCPH in Q3 2018 and held it in 19 quarters. The position peaked at $22.7M in Q4 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Invesco reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Invesco sold 65,578 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.03M.
- Invesco first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2018 and held it in 19 quarters.
- Invesco's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $22.7M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Invesco's 13F filing for Q2 2024, filed 13 Aug 2024.